fbpx

Research Reports

Going to Wait it Out

Nu Skin (NUS) is having troubles, but I feel this shall pass and I think NUS offers great potential for investors willing to wait it out.

Read More »

Back to Normal

I do believe Nu Skin’s (NUS) profit growth will go back to normal now that the China investigation is behind it.

Read More »

All Clear

Nu Skin (NUS) was under pressure because of China’s regulators. Now the fine is levied and NUS can rise again.

Read More »

Clearly a Top Stock

Nu Skin (NUS) is clearly a top stock. But now its jumped from $ 59 to $79 and is very extended. Let’s take a look at where NUS stands now, and if we should get some while its high.

Read More »

NUS is a Bargain

Nu Skin (NUS) is a bargain. The P/E is only 13 and the company is expected to grow 15% a year plus pay a 2% dividend. But there’s a catch…

Read More »

Lost the Momentum

Nu Skin (NUS) had serious momentum last quarter, now it doesn’t. After topping at 20 times earnings, the stock has corrected, and is now undervalued.

Read More »

I Sparked a Rally

It could be said my article on Nu Skin (NUS) Sunday sparked a rally — the stock’s gone from $54 to $59. Today I will buy NUS for the Growth Portfolio.

Read More »

Earnings

Not a member? Sign up here for $25 a month.